| abstract |
It is an object of the present invention to provide an agent for treating liver disease that has few side effects, can be administered orally, has high versatility, and is inexpensive.n n n The hepatic disease therapeutic agent of the present invention for solving such a problem comprises lipamycin B or a derivative of rifamycin B or a pharmacologically acceptable salt thereof as an active ingredient. When this liver disease treatment agent is administered to a patient with hepatic disease, liver function is improved and ALT values and AST values, which are indices of liver function, are lowered. |